Cytodyn Inc (CYDY)

[HyGro]

Why would Merck need a drug that failed to meet any of the CoV clinical trials' primary or secondary endpoints as confirmed by the FDA in the Statement? Merck has very thorough due diligence and considering a OTC penny stock under investigation by the SEC and DOJ and failed clinical trials -- wouldn't come close to being acceptable. They are very conservative.

Cytodyn shareholders should be realistic that no significant BP is going to look at OTC penny stocks for drugs. Hasn't happened anytime in the past decade and not likely to happen unless LL hits a home run and so far their is not any past evidence of that happening.